Neuronetics
STIM
66 hedge funds and large institutions have $84.2M invested in Neuronetics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
82% more capital invested
Capital invested by funds: $46.2M → $84.2M (+$38M)
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
4.38% more ownership
Funds ownership: 55.05% → 59.43% (+4.4%)
0% more funds holding
Funds holding: 66 → 66 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
35% less call options, than puts
Call options by funds: $11K | Put options by funds: $17K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$5.41M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
+$2.05M |
| 3 |
FWC
First Washington Corp
Seattle,
Washington
|
+$718K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$505K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$261K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
-$1.08M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$872K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$580K |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$349K |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$333K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| – | -$580 | -200 | Closed |
|
77
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$190 | +54 | New |
|
STIM Hedge Fund Activity: Q1 2024 in Review
66 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2024, worth a combined $84.2M — up 82% from $46.2M a quarter earlier.
Fund positioning in STIM was balanced in Q1 2024: 11 funds opened new positions, 11 closed out, 21 added to existing stakes and 19 trimmed.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $5.41M. The largest seller was Cannell Capital, cutting an estimated $1.08M.
- 66 institutional investors held Neuronetics (STIM) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $84.2M of Neuronetics stock for Q1 2024, up 82% quarter-over-quarter.
- 11 funds opened new Neuronetics positions in Q1 2024 and 11 closed out, a net change of 0 holders.
- The largest Neuronetics buyer in Q1 2024 was Divisadero Street Capital Management, an estimated $5.41M added.
- The largest Neuronetics seller in Q1 2024 was Cannell Capital, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2024.